Welcome to the Indiana Hemophilia & Thrombosis Center.

The IHTC was established in 1998 by Amy D. Shapiro, M.D., the center's co-medical director and pediatric hematologist, and Anne Greist, M.D., the center's co-medical director and adult hematologist. The center is located at the St. Vincent Hospital campus in Indianapolis, Indiana. Patient care, research and education are the focus of the center. Yet at the heart of all we do is patient care, as our mission statement indicates:

The Indiana Hemophilia & Thrombosis Center Inc. is committed to providing the highest quality comprehensive healthcare services to patients with bleeding and clotting disorders, and to their families.

Employment Opportunities

Click here to view current open positions.

School Educator Program

Click here to watch our educational videos designed for school staff members

IHTC News:

Hemaware Magazine recently featured the Partner’s in Bleeding Disorders program

The National Hemophilia Foundation’s monthly patient-oriented bleeding disorder magazine, “Hemaware” featured an article about the Partner’s in Bleeding Disorders program. The article features several quotes from Natalie and Dr. Shapiro and described the indirect benefits of the Partners Program to patients by increasing the competency of their providers. Check it out here.

IHTC has Moved!

As of September 8, the IHTC has a new home and address: 8326 Naab Rd, Indianapolis, IN 46260. For more information about our new home, visit www.ihtc.org/ihtcmove.

Biogen Idec’s ELOCTATE™ is now approved by the FDA for hemophilia A (factor VIII deficiency).

The US Food and Drug Administration (FDA) has approved Biogen Idec’s ELOCTATE™ for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with hemophilia A (factor VIII deficiency). Visit the National Hemophilia Foundation’s website for more details.